BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8646811)

  • 1. Concentration of mRNA for von Willebrand factor in platelets of type I von Willebrand disease.
    Takenaka T; Kuribayashi K; Tsukiyama M; Nakamine H; Fukuhara Y; Kuno T
    Clin Chim Acta; 1996 Feb; 245(1):125-7. PubMed ID: 8646811
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.
    Ginsburg D; Konkle BA; Gill JC; Montgomery RR; Bockenstedt PL; Johnson TA; Yang AY
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3723-7. PubMed ID: 2786201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease.
    Piao YC; Lavergne JM; Boyer-Neumann C; Schandelong A; Alessi MC; Meyer D
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):787-9. PubMed ID: 8292729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A de novo mutation in exon 28 of the von Willebrand factor gene in a patient with type IIA von Willebrand's disease coincides with an MboI polymorphism in the von Willebrand factor pseudogene.
    Pérez-Casal M; Daly M; Peake I
    Hum Mol Genet; 1993 Dec; 2(12):2159-61. PubMed ID: 7906590
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.
    Gallinaro L; Sartorello F; Pontara E; Cattini MG; Bertomoro A; Bartoloni L; Pagnan A; Casonato A
    Thromb Haemost; 2006 Dec; 96(6):711-6. PubMed ID: 17139363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation (Leu817Pro) causing type 2A von Willebrand disease.
    Gemmati D; Serino ML; Moratelli S; Ballerini G; Furbetta M; Lunghi B; Marchetti G; Bernardi F
    Br J Haematol; 1996 Jan; 92(1):241-3. PubMed ID: 8562403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fine structure of von Willebrand factor multimers and type IIA von Willebrand disease.
    Lynch DC
    Ann N Y Acad Sci; 1991; 614():138-52. PubMed ID: 2024881
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutations of von Willebrand factor gene in families with von Willebrand disease in the Aland Islands.
    Zhang ZP; Blombäck M; Nyman D; Anvret M
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7937-40. PubMed ID: 8367445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand disease, type 2B: A diagnosis more elusive than previously thought.
    Favaloro EJ
    Thromb Haemost; 2008 Mar; 99(3):630-1; author reply 632-3. PubMed ID: 18327414
    [No Abstract]   [Full Text] [Related]  

  • 10. In-frame deletion of von Willebrand factor A domains in a dominant type of von Willebrand disease.
    Bernardi F; Patracchini P; Gemmati D; Pinotti M; Schwienbacher C; Ballerini G; Marchetti G
    Hum Mol Genet; 1993 May; 2(5):545-8. PubMed ID: 8518792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand disease phenotype and von Willebrand factor marker genotype in Doberman Pinschers.
    Brooks MB; Erb HN; Foureman PA; Ray K
    Am J Vet Res; 2001 Mar; 62(3):364-9. PubMed ID: 11277201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of partial gene deletions in type III von Willebrand disease with alloantibody inhibitors.
    Mancuso DJ; Tuley EA; Castillo R; de Bosch N; Mannucci PM; Sadler JE
    Thromb Haemost; 1994 Aug; 72(2):180-5. PubMed ID: 7831648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three distinct candidate point mutations of the von Willebrand factor gene in four patients with type IIA von Willebrand disease.
    Sugiura I; Matsushita T; Tanimoto M; Takahashi I; Yamazaki T; Yamamoto K; Takamatsu J; Kamiya T; Saito H
    Thromb Haemost; 1992 Jun; 67(6):612-7. PubMed ID: 1380739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a new nonsense mutation in the von Willebrand factor gene in patients with von Willebrand disease type III.
    Zhang ZP; Falk G; Blombäck M; Egberg N; Anvret M
    Hum Mol Genet; 1992 Apr; 1(1):61-2. PubMed ID: 1301136
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
    Gaucher C; de Romeuf C; Rauïs-Morret M; Corazza F; Fondu P; Mazurier C
    Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different amino-acid substitutions in the leucine 694-proline 708 segment of recombinant von Willebrand factor.
    Hilbert L; Gaucher C; Mazurier C
    Br J Haematol; 1995 Dec; 91(4):983-90. PubMed ID: 8547152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation.
    McNicol A; Eyer E; Jackson EC; Israels SJ
    Thromb Haemost; 2007 Dec; 98(6):1382-4. PubMed ID: 18064343
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet von Willebrand factor in inherited and acquired bleeding disorders.
    Mannucci PM
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2428-32. PubMed ID: 7708659
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
    Baronciani L; Federici AB; Cozzi G; La Marca S; Punzo M; Rubini V; Canciani MT; Mannucci PM
    Haemophilia; 2008 May; 14(3):549-55. PubMed ID: 18328061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processing.
    Mohlke KL; Nichols WC; Rehemtulla A; Kaufman RJ; Fagerström HM; Ritvanen KL; Kekomăki R; Ginsburg D
    Br J Haematol; 1996 Oct; 95(1):184-91. PubMed ID: 8857958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.